Novel Nucleic Acid-Based Agents: siRNAs and miRNAs

Author(s): Tiago Campos Pereira, Iscia Lopes-Cendes

Journal Name: Central Nervous System Agents in Medicinal Chemistry
Formerly Current Medicinal Chemistry - Central Nervous System Agents

Volume 8 , Issue 2 , 2008

Become EABM
Become Reviewer


A novel class of therapeutic agents based on nucleic acids has emerged and shown very promising pre-clinical results, named small interfering RNAs (siRNAs) and microRNAs (miRNAs). siRNAs are small RNA duplexes capable of silencing undesired (i.e., mutant, exogenous or aberrant) gene expression with high specificity through a mechanism known as RNA interference. These agents have called special attention to neuroscience since they have been used to experimentally treat a variety of neurological diseases with distinct etiologies such as viral, prions, genetic disorders and others. siRNAs have also been used in other scenarios as: drug-receptor blockage, inhibition of pain signaling and regulation of behavior. Although in a very initial stage, miRNAs also promise novel therapeutic approaches. In this review article we intend to introduce clinicians and researchers to the novel field of si- and miRNA-mediated gene silencing strategies, its history, use in cell and animal models, delivery methods, current status and possible applications in future clinical practice.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2008
Page: [121 - 130]
Pages: 10
DOI: 10.2174/187152408784533932
Price: $65

Article Metrics

PDF: 3